Article

Transvitreal optic neurotomy improves visual acuity in recent-onset NAION

Transvitreal optic neurotomy (TON) improves the visual acuity and visual fields in patients with nonarteritic anterior ischemic optic neuropathy (NAION) of recent onset, reported Gholam Peyman, MD, at the American Academy of Ophthalmology annual meeting.

Transvitreal optic neurotomy (TON) improves the visual acuity and visual fields inpatients with nonarteritic anterior ischemic optic neuropathy (NAION) of recent onset, reportedGholam Peyman, MD, at the American Academy of Ophthalmology annual meeting.

Sixteen patients were included in this masked clinical trial. Eight patients were randomized toundergo TON and eight to observation. The TON procedure included pars plana vitrectomy. An MVR bladewas used to cut through the pars plana and the margin of the optic nerve was incised. Patients wereexamined at 1, 3, 7, and 28 days and then monthly to 6 months postoperatively, Dr. Peyman explained.He is from the Tulane Health Science Center, New Orleans.

The results showed that in the patients who underwent TON, the best-corrected visual acuity was 2.03± 0.9 compared with 1.11 ± 0.37 for the control patients. The mean visual acuity improvementwas greater in the surgical group than in the controls at 3 (0.8 ± 0.49 compared with 0.24± 0.45, respectively; p = 0.03) and 6 (1.04 ± 0.83 compared with 0.24 ± 0.45,respectively; p = 0.03) months postoperatively. Seventy-five percent of the surgical patientshad an increase in visual acuity compared with 25% of controls (p = 0.04). The visual fieldsimproved significantly (p = 0.01) in 75% of the surgical patients.

"TON may play a role in the treatment of NAION," Dr. Peyman concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.